| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-06 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-06 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-06 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-05 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-05 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.32 | 5e-05 |